US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

1.57

-0.0300-1.88%

Pre-market: 1.580.0100+0.64%09:00 EST

Volume:193.23K

Turnover:304.38K

Market Cap:41.74M

PE:-0.74

High:1.61

Open:1.61

Low:1.53

Close:1.60

52wk High:11.64

52wk Low:1.38

Shares:26.59M

Float Shares:20.18M

Volume Ratio:0.66

T/O Rate:0.96%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1078

EPS(LYR):-2.1100

ROE:-155.77%

ROA:-50.59%

PB:1.64

PE(LYR):-0.74

Loading ...

Overview Company News Filings

INmune Bio announces FDA alignment on phase 2b/3 registration pathway

INmune Bio Advances XPro1595 to Phase 2b/3 Trial in Early Alzheimer’s Disease

INmune Bio Inc - FDA Indicates No Objection to Integrated Phase 2B/3 Design

THOMSON REUTERS

BRIEF-Inmune Bio Advances Cordstrom™ Towards Uk Marketing Authorization In Rdeb

INmune Bio Inc: Submitted Pre-Submission Package for Cordstrom With UK's Mhra

THOMSON REUTERS

INmune Bio Advances Cordstrom™ Towards UK Marketing Authorization in Rdeb

THOMSON REUTERS

INmune Bio Submits CORDStrom Pre-Submission Package to UK MHRA for RDEB Review

INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives

INmune Bio Inc: Files for Common Stock Offering of $65 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS

INmune Bio Inc - Company Terminates Sales Agreement Effective December 19, 2025 - SEC Filing

THOMSON REUTERS

INmune Bio Inc - on Dec 5, Enters Amendment No. 5 to Rights Agreement - SEC Filing

THOMSON REUTERS

INmune Bio Reports Phase 2 Trial Data Showing XPro1595 Slows Neurodegeneration in Early Alzheimer’s Disease

INmune Bio Highlights CORDStrom Platform’s Promise in Stromal Cell Therapy Research

INmune Bio Inc. Updates Executive Compensation Agreements

INmune Bio Reports Positive Phase 2 Imaging Data for XPro1595 in Early Alzheimer's Disease

INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

INmune Bio Q3 net loss narrows to $6.5 mln, names new CEO

INmune Bio Q3 Adj. EPS $(0.24) Beats $(0.33) Estimate

INmune Bio Q3 Basic EPS USD -0.24

THOMSON REUTERS

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INMB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INMB\",,,,,undefined,":{"symbol":"INMB","market":"US","secType":"STK","nameCN":"INmune Bio Inc","latestPrice":1.57,"timestamp":1770843600000,"preClose":1.6,"halted":0,"volume":193232,"hourTrading":{"tag":"盘前","latestPrice":1.58,"preClose":1.57,"latestTime":"09:00 EST","volume":22264,"amount":36699.665904,"timestamp":1770904833663,"change":0.01,"changeRate":0.006369,"amplitude":0.070064},"delay":0,"changeRate":-0.018750000000000017,"floatShares":20177391,"shares":26585258,"eps":-2.107793,"marketStatus":"Pre-Mkt","change":-0.03,"latestTime":"02-12 09:01:08 EST","open":1.61,"high":1.61,"low":1.5293,"amount":304377.017464,"amplitude":0.050437,"askPrice":1.65,"askSize":2189,"bidPrice":1.58,"bidSize":159,"shortable":3,"etf":0,"ttmEps":-2.107793,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770906600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1549256400000,"exchange":"NASDAQ","adjPreClose":1.57,"preHourTrading":{"tag":"盘前","latestPrice":1.58,"preClose":1.57,"latestTime":"09:00 EST","volume":22264,"amount":36699.665904,"timestamp":1770904833663,"change":0.01,"changeRate":0.006369,"amplitude":0.070064},"postHourTrading":{"tag":"盘后","latestPrice":1.5204,"preClose":1.57,"latestTime":"17:56 EST","volume":1062,"amount":1646.908,"timestamp":1770850578412,"change":-0.0496,"changeRate":-0.031592,"amplitude":0.031592},"volumeRatio":0.6596483321570834,"impliedVol":7.2518,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INMB\",,,,,undefined,":{"symbol":"INMB","floatShares":20177391,"roa":"-50.59%","roe":"-155.77%","lyrEps":-2.109975,"volumeRatio":0.6596483321570834,"shares":26585258,"dividePrice":0,"high":1.61,"amplitude":0.050437,"preClose":1.6,"low":1.5293,"week52Low":1.38,"pbRate":"1.64","psRate":"834.78","week52High":11.64,"institutionHeld":0,"latestPrice":1.57,"committee":-0.864566,"eps":-2.107793,"divideRate":0,"volume":193232,"delay":0,"ttmEps":-2.107793,"open":1.61,"prevYearClose":1.56,"prevWeekClose":1.51,"prevMonthClose":1.59,"prevQuarterClose":1.56,"fiveDayClose":1.52,"twentyDayClose":1.5,"sixtyDayClose":1.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INMB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-30","symbol":"INMB","fiscalQuarterEnding":"2025/09","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2025-08-07","symbol":"INMB","fiscalQuarterEnding":"2025/06","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2025-05-08","symbol":"INMB","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-03-27","symbol":"INMB","fiscalQuarterEnding":"2024/12","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-10-31","symbol":"INMB","fiscalQuarterEnding":"2024/09","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.75,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1754888400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INMB","date":"2026-02-10","current":-0.744855,"percent":0.982941,"low":-27.668122,"twenty":-7.993914,"median":-4.776953,"eighty":-3.37445,"high":-0.756732,"avg":-6.505091,"sd":5.252099,"marketCap":40941297},"quantilePoints":[{"date":"2021-02-12","current":-23.97389,"twenty":-12.450217,"median":-8.58252,"eighty":-7.047033,"marketCap":268824480},{"date":"2021-02-19","current":-23.086412,"twenty":-12.81067,"median":-8.603835,"eighty":-7.047033,"marketCap":258872999},{"date":"2021-02-26","current":-19.452551,"twenty":-12.93723,"median":-8.628625,"eighty":-7.055897,"marketCap":218125716},{"date":"2021-03-05","current":-17.661464,"twenty":-13.288785,"median":-8.691424,"eighty":-7.061232,"marketCap":213686049},{"date":"2021-03-12","current":-19.648533,"twenty":-13.485656,"median":-8.735449,"eighty":-7.066547,"marketCap":237727596},{"date":"2021-03-19","current":-17.192466,"twenty":-13.837211,"median":-8.763426,"eighty":-7.068231,"marketCap":208011647},{"date":"2021-03-26","current":-15.291791,"twenty":-14.132517,"median":-8.797758,"eighty":-7.073626,"marketCap":185015384},{"date":"2021-04-01","current":-15.205397,"twenty":-14.405324,"median":-8.816597,"eighty":-7.079116,"marketCap":183970100},{"date":"2021-04-09","current":-14.526585,"twenty":-14.448952,"median":-8.86892,"eighty":-7.081879,"marketCap":175757149},{"date":"2021-04-16","current":-16.809863,"twenty":-14.481401,"median":-8.928017,"eighty":-7.082437,"marketCap":203382529},{"date":"2021-04-23","current":-14.748742,"twenty":-14.503825,"median":-8.985555,"eighty":-7.083384,"marketCap":178445024},{"date":"2021-04-30","current":-14.650005,"twenty":-14.557196,"median":-9.023825,"eighty":-7.086259,"marketCap":177250413},{"date":"2021-05-07","current":-10.944799,"twenty":-14.557196,"median":-9.09522,"eighty":-7.090468,"marketCap":159629900},{"date":"2021-05-14","current":-10.013109,"twenty":-14.532145,"median":-9.153781,"eighty":-7.091354,"marketCap":146041199},{"date":"2021-05-21","current":-14.272264,"twenty":-14.526585,"median":-9.169564,"eighty":-7.095026,"marketCap":208160973},{"date":"2021-05-28","current":-13.883207,"twenty":-14.506838,"median":-9.201475,"eighty":-7.10099,"marketCap":202486571},{"date":"2021-06-04","current":-13.688678,"twenty":-14.499641,"median":-9.222572,"eighty":-7.107607,"marketCap":199649370},{"date":"2021-06-11","current":-18.316414,"twenty":-14.560008,"median":-9.240497,"eighty":-7.112159,"marketCap":267144893},{"date":"2021-06-18","current":-18.10665,"twenty":-14.643256,"median":-9.258353,"eighty":-7.115581,"marketCap":264085485},{"date":"2021-06-25","current":-19.765907,"twenty":-14.664161,"median":-9.283837,"eighty":-7.124538,"marketCap":288285759},{"date":"2021-07-02","current":-18.39702,"twenty":-14.70431,"median":-9.302101,"eighty":-7.1541,"marketCap":268320533},{"date":"2021-07-09","current":-23.820718,"twenty":-14.750249,"median":-9.306408,"eighty":-7.170663,"marketCap":347425177},{"date":"2021-07-16","current":-25.5709,"twenty":-14.907866,"median":-9.347633,"eighty":-7.176186,"marketCap":372951575},{"date":"2021-07-23","current":-25.498255,"twenty":-15.115802,"median":-9.410754,"eighty":-7.184438,"marketCap":371892053},{"date":"2021-07-30","current":-18.427514,"twenty":-15.291475,"median":-9.475958,"eighty":-7.189362,"marketCap":268765292},{"date":"2021-08-06","current":-14.648204,"twenty":-15.291791,"median":-9.552978,"eighty":-7.204176,"marketCap":280249444},{"date":"2021-08-13","current":-15.342213,"twenty":-15.322044,"median":-9.602724,"eighty":-7.215371,"marketCap":293527213},{"date":"2021-08-20","current":-15.295945,"twenty":-15.33481,"median":-9.643151,"eighty":-7.224311,"marketCap":292642028},{"date":"2021-08-27","current":-18.534651,"twenty":-15.542604,"median":-9.67797,"eighty":-7.238398,"marketCap":354604950},{"date":"2021-09-03","current":-24.456857,"twenty":-15.700377,"median":-9.834212,"eighty":-7.241786,"marketCap":467908579},{"date":"2021-09-10","current":-19.956733,"twenty":-16.049173,"median":-10.013109,"eighty":-7.246093,"marketCap":381812208},{"date":"2021-09-17","current":-17.103106,"twenty":-16.294969,"median":-10.096999,"eighty":-7.253876,"marketCap":327216631},{"date":"2021-09-24","current":-18.78171,"twenty":-16.570102,"median":-10.158021,"eighty":-7.269875,"marketCap":359331676},{"date":"2021-10-01","current":-19.005524,"twenty":-16.926763,"median":-10.283748,"eighty":-7.275495,"marketCap":363613682},{"date":"2021-10-08","current":-16.114595,"twenty":-17.07161,"median":-10.299783,"eighty":-7.280483,"marketCap":308304437},{"date":"2021-10-15","current":-17.364223,"twenty":-17.215023,"median":-10.31393,"eighty":-7.292676,"marketCap":332212305},{"date":"2021-10-22","current":-18.61385,"twenty":-17.362358,"median":-10.361386,"eighty":-7.307494,"marketCap":356120172},{"date":"2021-10-29","current":-17.149734,"twenty":-17.438827,"median":-10.450716,"eighty":-7.322192,"marketCap":328108715},{"date":"2021-11-05","current":-10.66577,"twenty":-17.500376,"median":-10.469838,"eighty":-7.334332,"marketCap":254623933},{"date":"2021-11-12","current":-10.852627,"twenty":-17.438827,"median":-10.547639,"eighty":-7.334332,"marketCap":259084759},{"date":"2021-11-19","current":-9.993087,"twenty":-17.396814,"median":-10.493258,"eighty":-7.336898,"marketCap":238564961},{"date":"2021-11-26","current":-9.96319,"twenty":-17.377971,"median":-10.463597,"eighty":-7.347164,"marketCap":237851228},{"date":"2021-12-03","current":-8.386121,"twenty":-17.364223,"median":-10.413038,"eighty":-7.363704,"marketCap":200201859},{"date":"2021-12-10","current":-9.021433,"twenty":-17.354897,"median":-10.349909,"eighty":-7.364085,"marketCap":215368667},{"date":"2021-12-17","current":-8.072202,"twenty":-17.289618,"median":-10.31393,"eighty":-7.391283,"marketCap":192707672},{"date":"2021-12-23","current":-8.117047,"twenty":-17.234453,"median":-10.294863,"eighty":-7.411299,"marketCap":193778270},{"date":"2021-12-31","current":-7.623746,"twenty":-17.198105,"median":-10.277951,"eighty":-7.420777,"marketCap":182001690},{"date":"2022-01-07","current":-6.71936,"twenty":-17.188123,"median":-10.250588,"eighty":-7.385843,"marketCap":160411293},{"date":"2022-01-14","current":-6.562401,"twenty":-17.157195,"median":-10.158021,"eighty":-7.334332,"marketCap":156664200},{"date":"2022-01-21","current":-6.562401,"twenty":-17.121757,"median":-10.134036,"eighty":-7.313325,"marketCap":156664200},{"date":"2022-01-28","current":-6.637144,"twenty":-17.052748,"median":-10.0209,"eighty":-7.27235,"marketCap":158448530},{"date":"2022-02-04","current":-7.743334,"twenty":-16.975045,"median":-9.978127,"eighty":-7.267176,"marketCap":184856619},{"date":"2022-02-11","current":-7.945139,"twenty":-16.88904,"median":-9.880015,"eighty":-7.27235,"marketCap":189674310},{"date":"2022-02-18","current":-7.362147,"twenty":-16.851316,"median":-9.695826,"eighty":-7.276836,"marketCap":175756534},{"date":"2022-02-25","current":-6.995908,"twenty":-16.834735,"median":-9.652795,"eighty":-7.266444,"marketCap":167013316},{"date":"2022-03-04","current":-4.58647,"twenty":-16.800333,"median":-9.60783,"eighty":-7.241786,"marketCap":139153510},{"date":"2022-03-11","current":-3.779864,"twenty":-16.748358,"median":-9.597618,"eighty":-7.215371,"marketCap":114681069},{"date":"2022-03-18","current":-4.798425,"twenty":-16.669835,"median":-9.532204,"eighty":-7.176186,"marketCap":145584224},{"date":"2022-03-25","current":-5.295931,"twenty":-16.622116,"median":-9.475958,"eighty":-7.114659,"marketCap":160678539},{"date":"2022-04-01","current":-4.927953,"twenty":-16.540155,"median":-9.391739,"eighty":-7.09319,"marketCap":149514105},{"date":"2022-04-08","current":-4.557032,"twenty":-16.41045,"median":-9.356561,"eighty":-7.082937,"marketCap":138260355},{"date":"2022-04-14","current":-4.892628,"twenty":-16.340139,"median":-9.338705,"eighty":-7.074998,"marketCap":148442319},{"date":"2022-04-22","current":-4.051749,"twenty":-16.294969,"median":-9.313406,"eighty":-7.056964,"marketCap":122930065},{"date":"2022-04-29","current":-4.448051,"twenty":-16.264517,"median":-9.302101,"eighty":-7.028655,"marketCap":134953882},{"date":"2022-05-06","current":-4.123181,"twenty":-16.177128,"median":-9.283837,"eighty":-7.011001,"marketCap":134774422},{"date":"2022-05-13","current":-3.89259,"twenty":-16.108012,"median":-9.268083,"eighty":-6.992162,"marketCap":127237104},{"date":"2022-05-20","current":-4.035337,"twenty":-16.076093,"median":-9.252521,"eighty":-6.938131,"marketCap":131903063},{"date":"2022-05-27","current":-3.733373,"twenty":-16.049173,"median":-9.240497,"eighty":-6.904704,"marketCap":122032766},{"date":"2022-06-03","current":-3.810237,"twenty":-16.030915,"median":-9.222572,"eighty":-6.883794,"marketCap":124545205},{"date":"2022-06-10","current":-4.128671,"twenty":-16.030665,"median":-9.198666,"eighty":-6.853897,"marketCap":134953882},{"date":"2022-06-17","current":-3.8871,"twenty":-15.988728,"median":-9.169073,"eighty":-6.816526,"marketCap":127057644},{"date":"2022-06-24","current":-4.485538,"twenty":-15.776756,"median":-9.153781,"eighty":-6.781965,"marketCap":146618779},{"date":"2022-07-01","current":-4.814953,"twenty":-15.676991,"median":-9.09522,"eighty":-6.723374,"marketCap":157386376},{"date":"2022-07-08","current":-5.60555,"twenty":-15.638009,"median":-9.045047,"eighty":-6.718318,"marketCap":183228608},{"date":"2022-07-15","current":-5.622021,"twenty":-15.604919,"median":-9.019989,"eighty":-6.69376,"marketCap":183766988},{"date":"2022-07-22","current":-5.122407,"twenty":-15.593228,"median":-8.985555,"eighty":-6.666807,"marketCap":167436133},{"date":"2022-07-29","current":-4.924758,"twenty":-15.517879,"median":-8.928017,"eighty":-6.648259,"marketCap":160975575},{"date":"2022-08-05","current":-5.672616,"twenty":-15.443115,"median":-8.900085,"eighty":-6.630424,"marketCap":186458888},{"date":"2022-08-12","current":-5.137567,"twenty":-15.378871,"median":-8.829808,"eighty":-6.614721,"marketCap":168871812},{"date":"2022-08-19","current":-4.782687,"twenty":-15.344244,"median":-8.813572,"eighty":-6.562401,"marketCap":157206916},{"date":"2022-08-26","current":-4.54792,"twenty":-15.331109,"median":-8.794096,"eighty":-6.517939,"marketCap":149490138},{"date":"2022-09-02","current":-4.449646,"twenty":-15.307049,"median":-8.747284,"eighty":-6.410235,"marketCap":146259859},{"date":"2022-09-09","current":-4.515162,"twenty":-15.294283,"median":-8.720132,"eighty":-6.30054,"marketCap":148413378},{"date":"2022-09-16","current":-4.280395,"twenty":-15.291791,"median":-8.678032,"eighty":-6.169279,"marketCap":140696600},{"date":"2022-09-23","current":-3.772645,"twenty":-15.291475,"median":-8.619446,"eighty":-6.093555,"marketCap":124006825},{"date":"2022-09-30","current":-3.385007,"twenty":-15.276609,"median":-8.59768,"eighty":-6.018493,"marketCap":111265169},{"date":"2022-10-07","current":-3.587015,"twenty":-15.235172,"median":-8.571362,"eighty":-5.981814,"marketCap":117905187},{"date":"2022-10-14","current":-3.385007,"twenty":-15.195523,"median":-8.53371,"eighty":-5.928611,"marketCap":111265169},{"date":"2022-10-21","current":-4.040169,"twenty":-15.115802,"median":-8.511397,"eighty":-5.824533,"marketCap":132800363},{"date":"2022-10-28","current":-4.264016,"twenty":-15.007186,"median":-8.5084,"eighty":-5.653431,"marketCap":140158220},{"date":"2022-11-04","current":-4.484049,"twenty":-14.984687,"median":-8.485886,"eighty":-5.582491,"marketCap":139619841},{"date":"2022-11-11","current":-4.32267,"twenty":-14.965,"median":-8.479856,"eighty":-5.545911,"marketCap":134594962},{"date":"2022-11-18","current":-4.224689,"twenty":-14.935497,"median":-8.461395,"eighty":-5.484764,"marketCap":131544143},{"date":"2022-11-25","current":-4.069073,"twenty":-14.902739,"median":-8.443693,"eighty":-5.34109,"marketCap":126698724},{"date":"2022-12-02","current":-3.984464,"twenty":-14.831046,"median":-8.436976,"eighty":-5.213846,"marketCap":124064252},{"date":"2022-12-09","current":-4.443704,"twenty":-14.765317,"median":-8.423524,"eighty":-5.122277,"marketCap":138363621},{"date":"2022-12-16","current":-4.305379,"twenty":-14.762504,"median":-8.411722,"eighty":-5.080786,"marketCap":134056582},{"date":"2022-12-23","current":-4.051782,"twenty":-14.751002,"median":-8.385906,"eighty":-5.017829,"marketCap":126160344},{"date":"2022-12-30","current":-3.654097,"twenty":-14.749992,"median":-8.37342,"eighty":-4.979236,"marketCap":113777608},{"date":"2023-01-06","current":-4.034492,"twenty":-14.748992,"median":-8.347696,"eighty":-4.957396,"marketCap":125621965},{"date":"2023-01-13","current":-5.094987,"twenty":-14.748742,"median":-8.333801,"eighty":-4.927314,"marketCap":158642595},{"date":"2023-01-20","current":-4.507103,"twenty":-14.726526,"median":-8.331087,"eighty":-4.92471,"marketCap":140337680},{"date":"2023-01-27","current":-4.812572,"twenty":-14.70431,"median":-8.293589,"eighty":-4.863379,"marketCap":149849058},{"date":"2023-02-03","current":-4.956661,"twenty":-14.698159,"median":-8.273824,"eighty":-4.863379,"marketCap":154335557},{"date":"2023-02-10","current":-5.463854,"twenty":-14.690071,"median":-8.2591,"eighty":-4.883594,"marketCap":170128032},{"date":"2023-02-17","current":-5.671342,"twenty":-14.682653,"median":-8.256702,"eighty":-4.898729,"marketCap":176588590},{"date":"2023-02-24","current":-5.175676,"twenty":-14.675318,"median":-8.231631,"eighty":-4.911534,"marketCap":161155035},{"date":"2023-03-03","current":-5.752132,"twenty":-14.665067,"median":-8.219205,"eighty":-4.924687,"marketCap":157027456},{"date":"2023-03-10","current":-4.542541,"twenty":-14.662347,"median":-8.214213,"eighty":-4.911534,"marketCap":124006825},{"date":"2023-03-17","current":-4.325603,"twenty":-14.65741,"median":-8.196054,"eighty":-4.860048,"marketCap":118084647},{"date":"2023-03-24","current":-4.312456,"twenty":-14.650005,"median":-8.176841,"eighty":-4.829288,"marketCap":117725727},{"date":"2023-03-31","current":-4.246717,"twenty":-14.649285,"median":-8.139447,"eighty":-4.788982,"marketCap":115931127},{"date":"2023-04-06","current":-4.273012,"twenty":-14.646315,"median":-8.119592,"eighty":-4.766844,"marketCap":116648967},{"date":"2023-04-14","current":-5.686393,"twenty":-14.635094,"median":-8.112902,"eighty":-4.766844,"marketCap":155232856},{"date":"2023-04-21","current":-5.226223,"twenty":-14.618482,"median":-8.069415,"eighty":-4.770788,"marketCap":142670660},{"date":"2023-04-28","current":-4.503098,"twenty":-14.607952,"median":-8.01182,"eighty":-4.761822,"marketCap":122930065},{"date":"2023-05-05","current":-5.037566,"twenty":-14.597099,"median":-7.994008,"eighty":-4.76177,"marketCap":135671722},{"date":"2023-05-12","current":-5.550651,"twenty":-14.590945,"median":-7.985903,"eighty":-4.766103,"marketCap":149490138},{"date":"2023-05-19","current":-4.784355,"twenty":-14.565891,"median":-7.963363,"eighty":-4.766844,"marketCap":128852244},{"date":"2023-05-26","current":-4.744374,"twenty":-14.555413,"median":-7.950009,"eighty":-4.766844,"marketCap":127775484},{"date":"2023-06-02","current":-5.224142,"twenty":-14.554383,"median":-7.945139,"eighty":-4.768987,"marketCap":140696600},{"date":"2023-06-09","current":-5.597295,"twenty":-14.526585,"median":-7.899933,"eighty":-4.777991,"marketCap":150746358},{"date":"2023-06-16","current":-6.143698,"twenty":-14.526585,"median":-7.877871,"eighty":-4.782687,"marketCap":165462073},{"date":"2023-06-23","current":-6.05041,"twenty":-14.506838,"median":-7.862922,"eighty":-4.784021,"marketCap":162949634},{"date":"2023-06-30","current":-5.670593,"twenty":-14.499641,"median":-7.852366,"eighty":-4.792797,"marketCap":152720417},{"date":"2023-07-07","current":-5.803862,"twenty":-14.498135,"median":-7.810603,"eighty":-4.804084,"marketCap":156309616},{"date":"2023-07-14","current":-6.563495,"twenty":-14.489768,"median":-7.793419,"eighty":-4.813524,"marketCap":176768050},{"date":"2023-07-21","current":-5.970448,"twenty":-14.463085,"median":-7.748803,"eighty":-4.820117,"marketCap":160796115},{"date":"2023-07-28","current":-5.570642,"twenty":-14.436261,"median":-7.738829,"eighty":-4.829118,"marketCap":150028518},{"date":"2023-08-04","current":-5.743891,"twenty":-14.416574,"median":-7.728386,"eighty":-4.831169,"marketCap":154694476},{"date":"2023-08-11","current":-5.692131,"twenty":-14.371464,"median":-7.688821,"eighty":-4.831571,"marketCap":151382212},{"date":"2023-08-18","current":-4.295344,"twenty":-14.323598,"median":-7.661117,"eighty":-4.831169,"marketCap":114234680},{"date":"2023-08-25","current":-4.491863,"twenty":-14.298101,"median":-7.639701,"eighty":-4.804084,"marketCap":119461104},{"date":"2023-09-01","current":-4.548012,"twenty":-14.216365,"median":-7.623746,"eighty":-4.772589,"marketCap":120954367},{"date":"2023-09-08","current":-5.387195,"twenty":-14.117531,"median":-7.614167,"eighty":-4.766103,"marketCap":143272451},{"date":"2023-09-15","current":-5.583709,"twenty":-14.05265,"median":-7.577863,"eighty":-4.766844,"marketCap":148498742},{"date":"2023-09-22","current":-4.811206,"twenty":-14.02856,"median":-7.55676,"eighty":-4.766844,"marketCap":127954013},{"date":"2023-09-29","current":-4.750218,"twenty":-14.001703,"median":-7.552768,"eighty":-4.752314,"marketCap":126332060},{"date":"2023-10-06","current":-4.621468,"twenty":-13.959944,"median":-7.535451,"eighty":-4.743442,"marketCap":122907939},{"date":"2023-10-13","current":-4.817982,"twenty":-13.937214,"median":-7.514461,"eighty":-4.729837,"marketCap":128134230},{"date":"2023-10-20","current":-5.06193,"twenty":-13.902659,"median":-7.512855,"eighty":-4.728197,"marketCap":134622039},{"date":"2023-10-27","current":-4.729889,"twenty":-13.892933,"median":-7.487811,"eighty":-4.729043,"marketCap":125791410},{"date":"2023-11-03","current":-4.467157,"twenty":-13.880922,"median":-7.456035,"eighty":-4.715928,"marketCap":122547505},{"date":"2023-11-10","current":-4.565697,"twenty":-13.860422,"median":-7.432279,"eighty":-4.714445,"marketCap":125250759},{"date":"2023-11-17","current":-4.63796,"twenty":-13.841435,"median":-7.419099,"eighty":-4.7061,"marketCap":127233145},{"date":"2023-11-24","current":-6.116063,"twenty":-13.836499,"median":-7.377684,"eighty":-4.70881,"marketCap":167781952},{"date":"2023-12-01","current":-6.208034,"twenty":-13.834818,"median":-7.362147,"eighty":-4.711426,"marketCap":170304989},{"date":"2023-12-08","current":-6.667888,"twenty":-13.8296,"median":-7.334332,"eighty":-4.714372,"marketCap":182920173},{"date":"2023-12-15","current":-7.383947,"twenty":-13.798441,"median":-7.334332,"eighty":-4.715483,"marketCap":202563818},{"date":"2023-12-22","current":-6.766428,"twenty":-13.757962,"median":-7.311867,"eighty":-4.720539,"marketCap":185623427},{"date":"2023-12-29","current":-7.521903,"twenty":-13.752838,"median":-7.304578,"eighty":-4.726119,"marketCap":206348373},{"date":"2024-01-05","current":-7.942342,"twenty":-13.714342,"median":-7.32199,"eighty":-4.727112,"marketCap":217882256},{"date":"2024-01-12","current":-7.607305,"twenty":-13.688678,"median":-7.334332,"eighty":-4.729043,"marketCap":208691193},{"date":"2024-01-19","current":-7.121173,"twenty":-13.663718,"median":-7.334332,"eighty":-4.729889,"marketCap":195355141},{"date":"2024-01-26","current":-7.7584,"twenty":-13.616139,"median":-7.342563,"eighty":-4.733169,"marketCap":212836182},{"date":"2024-02-02","current":-6.917523,"twenty":-13.586886,"median":-7.362147,"eighty":-4.740082,"marketCap":189768416},{"date":"2024-02-09","current":-7.817524,"twenty":-13.586886,"median":-7.383947,"eighty":-4.740082,"marketCap":214458134},{"date":"2024-02-16","current":-9.052561,"twenty":-13.586886,"median":-7.432279,"eighty":-4.740082,"marketCap":248338915},{"date":"2024-02-23","current":-8.320079,"twenty":-13.586886,"median":-7.45621,"eighty":-4.740082,"marketCap":228244729},{"date":"2024-03-01","current":-7.620444,"twenty":-13.579863,"median":-7.512855,"eighty":-4.741077,"marketCap":209051627},{"date":"2024-03-08","current":-8.211685,"twenty":-13.579863,"median":-7.532316,"eighty":-4.741077,"marketCap":225271150},{"date":"2024-03-15","current":-7.515334,"twenty":-13.579863,"median":-7.555984,"eighty":-4.741077,"marketCap":206168156},{"date":"2024-03-22","current":-7.830663,"twenty":-13.579863,"median":-7.55676,"eighty":-4.741077,"marketCap":214818568},{"date":"2024-03-28","current":-7.640152,"twenty":-13.579863,"median":-7.591653,"eighty":-4.741077,"marketCap":209592277},{"date":"2024-04-05","current":-6.157403,"twenty":-13.586886,"median":-7.598129,"eighty":-4.740082,"marketCap":184771348},{"date":"2024-04-12","current":-6.571901,"twenty":-13.586886,"median":-7.567889,"eighty":-4.740082,"marketCap":197209614},{"date":"2024-04-19","current":-5.286356,"twenty":-13.586886,"median":-7.55549,"eighty":-4.740082,"marketCap":158632962},{"date":"2024-04-26","current":-6.782219,"twenty":-13.579863,"median":-7.525542,"eighty":-4.741077,"marketCap":203520837},{"date":"2024-05-03","current":-7.329371,"twenty":-13.579863,"median":-7.515362,"eighty":-4.741077,"marketCap":219939763},{"date":"2024-05-10","current":-7.092302,"twenty":-13.579863,"median":-7.483373,"eighty":-4.741077,"marketCap":212825808},{"date":"2024-05-17","current":-6.405477,"twenty":-13.579863,"median":-7.442187,"eighty":-4.741077,"marketCap":220969731},{"date":"2024-05-24","current":-5.80335,"twenty":-13.579863,"median":-7.419099,"eighty":-4.741077,"marketCap":200198181},{"date":"2024-05-31","current":-5.46788,"twenty":-13.579863,"median":-7.373138,"eighty":-4.741077,"marketCap":188625460},{"date":"2024-06-07","current":-5.13241,"twenty":-13.579863,"median":-7.354655,"eighty":-4.741077,"marketCap":177052739},{"date":"2024-06-14","current":-5.206959,"twenty":-13.586886,"median":-7.334332,"eighty":-4.740082,"marketCap":179624455},{"date":"2024-06-21","current":-4.415593,"twenty":-13.593908,"median":-7.299729,"eighty":-4.729889,"marketCap":152324703},{"date":"2024-06-28","current":-4.983312,"twenty":-13.61107,"median":-7.278178,"eighty":-4.729043,"marketCap":171909308},{"date":"2024-07-05","current":-4.581894,"twenty":-13.61107,"median":-7.264982,"eighty":-4.722399,"marketCap":158061607},{"date":"2024-07-12","current":-5.184021,"twenty":-13.61107,"median":-7.239596,"eighty":-4.712359,"marketCap":178833158},{"date":"2024-07-15","current":-5.298711,"twenty":-13.61107,"median":-7.239421,"eighty":-4.712359,"marketCap":182789643},{"date":"2024-08-02","current":-4.146018,"twenty":-13.688678,"median":-7.177561,"eighty":-4.698344,"marketCap":156479013},{"date":"2024-08-09","current":-3.97829,"twenty":-13.688678,"median":-7.1193,"eighty":-4.673493,"marketCap":150148636},{"date":"2024-08-16","current":-3.597,"twenty":-13.688678,"median":-7.098705,"eighty":-4.660833,"marketCap":135757966},{"date":"2024-08-23","current":-3.377096,"twenty":-13.688678,"median":-7.081357,"eighty":-4.634575,"marketCap":127458353},{"date":"2024-08-30","current":-3.591764,"twenty":-13.688678,"median":-7.049362,"eighty":-4.618844,"marketCap":135560357},{"date":"2024-09-06","current":-3.141485,"twenty":-13.688678,"median":-7.002701,"eighty":-4.598246,"marketCap":118565910},{"date":"2024-09-13","current":-3.345681,"twenty":-13.688678,"median":-6.952929,"eighty":-4.58647,"marketCap":126272694},{"date":"2024-09-20","current":-3.131237,"twenty":-13.688678,"median":-6.906659,"eighty":-4.580678,"marketCap":118179163},{"date":"2024-09-27","current":-2.903924,"twenty":-13.688678,"median":-6.870645,"eighty":-4.565697,"marketCap":109599899},{"date":"2024-10-04","current":-3.102983,"twenty":-13.688678,"median":-6.81347,"eighty":-4.55338,"marketCap":117112796},{"date":"2024-10-11","current":-2.939052,"twenty":-13.688678,"median":-6.769054,"eighty":-4.542541,"marketCap":110925705},{"date":"2024-10-18","current":-2.927343,"twenty":-13.688678,"median":-6.723897,"eighty":-4.515162,"marketCap":110483770},{"date":"2024-10-25","current":-3.056146,"twenty":-13.688678,"median":-6.695693,"eighty":-4.499873,"marketCap":115345055},{"date":"2024-10-31","current":-3.483538,"twenty":-13.688678,"median":-6.649164,"eighty":-4.491863,"marketCap":131475686},{"date":"2024-11-08","current":-3.341555,"twenty":-13.70151,"median":-6.620238,"eighty":-4.483072,"marketCap":137912645},{"date":"2024-11-15","current":-2.922517,"twenty":-13.70151,"median":-6.577909,"eighty":-4.471791,"marketCap":120618133},{"date":"2024-11-22","current":-2.557203,"twenty":-13.70151,"median":-6.57735,"eighty":-4.449646,"marketCap":105540866},{"date":"2024-11-29","current":-2.712999,"twenty":-13.70151,"median":-6.571901,"eighty":-4.440809,"marketCap":111970877},{"date":"2024-12-06","current":-2.616298,"twenty":-13.70151,"median":-6.517555,"eighty":-4.427747,"marketCap":107979836},{"date":"2024-12-13","current":-2.616298,"twenty":-13.70151,"median":-6.405477,"eighty":-4.410823,"marketCap":107979836},{"date":"2024-12-20","current":-2.374545,"twenty":-13.70151,"median":-6.323611,"eighty":-4.40331,"marketCap":98002233},{"date":"2024-12-27","current":-2.541086,"twenty":-13.70151,"median":-6.286866,"eighty":-4.385676,"marketCap":104875693},{"date":"2025-01-03","current":-2.648531,"twenty":-13.70151,"median":-6.226059,"eighty":-4.338224,"marketCap":109310183},{"date":"2025-01-10","current":-2.847305,"twenty":-13.714342,"median":-6.206881,"eighty":-4.327301,"marketCap":117513990},{"date":"2025-01-17","current":-3.610168,"twenty":-13.714342,"median":-6.170541,"eighty":-4.309625,"marketCap":148998870},{"date":"2025-01-24","current":-4.233352,"twenty":-13.714342,"median":-6.147785,"eighty":-4.281536,"marketCap":174718913},{"date":"2025-01-31","current":-4.953237,"twenty":-13.714342,"median":-6.116063,"eighty":-4.280362,"marketCap":204429998},{"date":"2025-02-07","current":-5.264829,"twenty":-13.714342,"median":-6.068848,"eighty":-4.280362,"marketCap":217290019},{"date":"2025-02-14","current":-4.996215,"twenty":-13.714342,"median":-6.034452,"eighty":-4.280362,"marketCap":206203794},{"date":"2025-02-21","current":-4.883397,"twenty":-13.714342,"median":-6.010371,"eighty":-4.280362,"marketCap":201547579},{"date":"2025-02-28","current":-4.217235,"twenty":-13.714342,"median":-5.973476,"eighty":-4.272126,"marketCap":174053740},{"date":"2025-03-07","current":-4.308564,"twenty":-13.727174,"median":-5.962507,"eighty":-4.268681,"marketCap":177823057},{"date":"2025-03-14","current":-4.319309,"twenty":-13.727174,"median":-5.943795,"eighty":-4.268681,"marketCap":178266506},{"date":"2025-03-21","current":-4.373031,"twenty":-13.727174,"median":-5.943795,"eighty":-4.27178,"marketCap":180483751},{"date":"2025-03-28","current":-4.037679,"twenty":-13.727174,"median":-5.943795,"eighty":-4.280346,"marketCap":169913604},{"date":"2025-04-04","current":-4.233841,"twenty":-13.727174,"median":-5.943795,"eighty":-4.27178,"marketCap":178168516},{"date":"2025-04-11","current":-3.66715,"twenty":-13.714342,"median":-5.939937,"eighty":-4.261832,"marketCap":154320993},{"date":"2025-04-17","current":-3.983189,"twenty":-13.714342,"median":-5.898886,"eighty":-4.246717,"marketCap":167620573},{"date":"2025-04-25","current":-4.380963,"twenty":-13.727174,"median":-5.797616,"eighty":-4.237709,"marketCap":184359700},{"date":"2025-05-02","current":-4.145464,"twenty":-13.727174,"median":-5.743891,"eighty":-4.236718,"marketCap":174449432},{"date":"2025-05-09","current":-3.872377,"twenty":-13.727174,"median":-5.710574,"eighty":-4.226225,"marketCap":162957375},{"date":"2025-05-16","current":-4.147555,"twenty":-13.727174,"median":-5.68392,"eighty":-4.218916,"marketCap":169203648},{"date":"2025-05-23","current":-4.267032,"twenty":-13.727174,"median":-5.66393,"eighty":-4.218916,"marketCap":174077827},{"date":"2025-05-30","current":-4.18738,"twenty":-13.727174,"median":-5.630144,"eighty":-4.195871,"marketCap":170828374},{"date":"2025-06-06","current":-4.181691,"twenty":-13.727174,"median":-5.60555,"eighty":-4.18746,"marketCap":170596270},{"date":"2025-06-13","current":-4.505986,"twenty":-13.727174,"median":-5.583709,"eighty":-4.18746,"marketCap":183826185},{"date":"2025-06-20","current":-4.119108,"twenty":-13.740006,"median":-5.565548,"eighty":-4.185357,"marketCap":168043129},{"date":"2025-06-27","current":-3.572928,"twenty":-13.740006,"median":-5.548847,"eighty":-4.164748,"marketCap":145761167},{"date":"2025-07-03","current":-1.648708,"twenty":-13.740006,"median":-5.528092,"eighty":-4.155932,"marketCap":67260702},{"date":"2025-07-11","current":-1.453209,"twenty":-13.740006,"median":-5.491798,"eighty":-4.147997,"marketCap":59285125},{"date":"2025-07-18","current":-1.459726,"twenty":-13.593908,"median":-5.471955,"eighty":-4.130089,"marketCap":59550977},{"date":"2025-07-25","current":-1.811624,"twenty":-13.384408,"median":-5.443985,"eighty":-4.120534,"marketCap":73907017},{"date":"2025-08-01","current":-1.779041,"twenty":-13.250549,"median":-5.40707,"eighty":-4.115166,"marketCap":72577754},{"date":"2025-08-08","current":-1.818141,"twenty":-13.072922,"median":-5.38086,"eighty":-4.092052,"marketCap":74172869},{"date":"2025-08-15","current":-1.173414,"twenty":-12.856875,"median":-5.344496,"eighty":-4.074836,"marketCap":65133882},{"date":"2025-08-22","current":-1.12552,"twenty":-12.287556,"median":-5.306639,"eighty":-4.051756,"marketCap":62475356},{"date":"2025-08-29","current":-1.000994,"twenty":-11.707447,"median":-5.267434,"eighty":-4.035805,"marketCap":55563189},{"date":"2025-09-05","current":-0.919574,"twenty":-11.57763,"median":-5.24334,"eighty":-4.011437,"marketCap":51043695},{"date":"2025-09-12","current":-0.943521,"twenty":-11.398824,"median":-5.220964,"eighty":-3.983444,"marketCap":52372958},{"date":"2025-09-19","current":-0.943521,"twenty":-11.205601,"median":-5.193589,"eighty":-3.970934,"marketCap":52372958},{"date":"2025-09-26","current":-0.972258,"twenty":-10.982131,"median":-5.146132,"eighty":-3.961591,"marketCap":53968073},{"date":"2025-10-03","current":-1.024941,"twenty":-10.876545,"median":-5.116358,"eighty":-3.939387,"marketCap":56892452},{"date":"2025-10-10","current":-0.94831,"twenty":-10.757669,"median":-5.094423,"eighty":-3.903264,"marketCap":52638810},{"date":"2025-10-17","current":-0.886048,"twenty":-10.662562,"median":-5.062692,"eighty":-3.87591,"marketCap":49182727},{"date":"2025-10-24","current":-0.857311,"twenty":-10.46859,"median":-5.049811,"eighty":-3.85516,"marketCap":47587611},{"date":"2025-10-31","current":-0.828574,"twenty":-10.31393,"median":-5.025749,"eighty":-3.812433,"marketCap":45992496},{"date":"2025-11-07","current":-0.868643,"twenty":-10.289864,"median":-5.00406,"eighty":-3.779864,"marketCap":43333970},{"date":"2025-11-14","current":-0.762061,"twenty":-10.287058,"median":-4.986438,"eighty":-3.747113,"marketCap":38016918},{"date":"2025-11-21","current":-0.794035,"twenty":-10.153436,"median":-4.960489,"eighty":-3.723545,"marketCap":39612034},{"date":"2025-11-28","current":-0.927263,"twenty":-9.955716,"median":-4.956661,"eighty":-3.695003,"marketCap":46258348},{"date":"2025-12-05","current":-1.00187,"twenty":-9.350301,"median":-4.934681,"eighty":-3.671682,"marketCap":49980285},{"date":"2025-12-12","current":-1.140426,"twenty":-9.168182,"median":-4.926355,"eighty":-3.654196,"marketCap":56892452},{"date":"2025-12-19","current":-0.969895,"twenty":-8.857327,"median":-4.912257,"eighty":-3.631916,"marketCap":48385169},{"date":"2025-12-26","current":-0.94325,"twenty":-8.555781,"median":-4.898573,"eighty":-3.61175,"marketCap":47055906},{"date":"2026-01-02","current":-0.831339,"twenty":-8.469203,"median":-4.88389,"eighty":-3.592811,"marketCap":41473002},{"date":"2026-01-09","current":-0.815352,"twenty":-8.354896,"median":-4.860333,"eighty":-3.573554,"marketCap":40675444},{"date":"2026-01-16","current":-0.868643,"twenty":-8.302342,"median":-4.831212,"eighty":-3.511157,"marketCap":43333970},{"date":"2026-01-23","current":-0.905946,"twenty":-8.209201,"median":-4.822923,"eighty":-3.498095,"marketCap":45194938},{"date":"2026-01-30","current":-0.831339,"twenty":-8.134947,"median":-4.804816,"eighty":-3.465315,"marketCap":41473002},{"date":"2026-02-06","current":-0.756732,"twenty":-8.000152,"median":-4.782586,"eighty":-3.385007,"marketCap":37751066},{"date":"2026-02-10","current":-0.820681,"twenty":-7.993914,"median":-4.776953,"eighty":-3.37445,"marketCap":40941297}],"updateTime":1770863690788},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INMB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610925323","title":"INmune Bio announces FDA alignment on phase 2b/3 registration pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2610925323","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610925323?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:20","pubTimestamp":1770898801,"startTime":"0","endTime":"0","summary":"INmune Bio (INMB) announced that it received the official minutes from its End-of-Phase 2 meeting with the U.S. Food and Drug Administration, FDA. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inmune-bio-announces-fda-alignment-on-phase-2b-3-registration-pathway-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inmune-bio-announces-fda-alignment-on-phase-2b-3-registration-pathway-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2610192877","title":"INmune Bio Advances XPro1595 to Phase 2b/3 Trial in Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2610192877","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610192877?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:00","pubTimestamp":1770897630,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. announced that it has received official feedback from the U.S. Food and Drug Administration  confirming regulatory alignment on the company’s proposed integrated Phase 2b/3 clinical development strategy for XPro1595 in early Alzheimer’s disease. The FDA agreed with INmune Bio’s enrichment-led trial design and confirmed the use of the Clinical Dementia Rating Scale Sum of Boxes  as the sole primary endpoint for the registrational Phase 3 portion of the study. INmune Bio is incorporating the FDA’s feedback into its final Phase 2b/3 protocol and plans to submit the protocol for agency review. The company stated that additional updates on study timelines will be provided as the protocol is finalized. Results from the Phase 2 MINDFuL trial, which informed the new study design, have already been presented.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL74yC76:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BKPKM429.USD","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014005.SGD","NDAQ","BK4585","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","INMB","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BGHQF748.EUR","BK4139","LU2095319765.USD"],"gpt_icon":0},{"id":"2610280739","title":"INmune Bio Inc - FDA Indicates No Objection to Integrated Phase 2B/3 Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2610280739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610280739?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:00","pubTimestamp":1770897613,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z80T5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2610948621","title":"BRIEF-Inmune Bio Advances Cordstrom™ Towards Uk Marketing Authorization In Rdeb","url":"https://stock-news.laohu8.com/highlight/detail?id=2610948621","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610948621?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:21","pubTimestamp":1770736876,"startTime":"0","endTime":"0","summary":"BRIEF-Inmune Bio Advances Cordstrom™ Towards Uk Marketing Authorization In RdebFeb 10 (Reuters) - INmune Bio Inc INMB.O:INMUNE BIO ADVANCES CORDSTROM™ TOWARDS UK MARKETING AUTHORIZATION IN RDEBSource text: ID:nGNE13ldGMFurther company coverage: INMB.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z613J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2610284156","title":"INmune Bio Inc: Submitted Pre-Submission Package for Cordstrom With UK's Mhra","url":"https://stock-news.laohu8.com/highlight/detail?id=2610284156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610284156?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:10","pubTimestamp":1770729017,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2610628302","title":"INmune Bio Advances Cordstrom™ Towards UK Marketing Authorization in Rdeb","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628302?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:03","pubTimestamp":1770728611,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z613J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2610628831","title":"INmune Bio Submits CORDStrom Pre-Submission Package to UK MHRA for RDEB Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628831?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728449,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. has submitted a pre-submission package to the United Kingdom's Medicines and Healthcare Products Regulatory Agency  for CORDStrom, a treatment for recessive dystrophic epidermolysis bullosa . This pre-submission process is intended to obtain early feedback from the MHRA, which may help streamline the subsequent Marketing Authorization Application  and potentially reduce the time required to bring the therapy to market. INmune Bio plans to file a full MAA with the MHRA following receipt of feedback, targeted for mid-summer 2026, with additional regulatory submissions in the EU and U.S. expected in the fourth quarter of 2026, pending regulatory alignment and manufacturing readiness.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL2QVxB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4112","LU0314104364.USD","LU2210149790.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","BK4585","SG9999014039.USD","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","INMB"],"gpt_icon":0},{"id":"2606780772","title":"INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780772","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606780772?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:25","pubTimestamp":1769523900,"startTime":"0","endTime":"0","summary":"Boca Raton, FL, Jan.  27, 2026  (GLOBE NEWSWIRE) --  INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/27/3226623/0/en/INmune-Bio-Inc-Issues-Shareholder-Letter-Reviewing-2025-Milestones-and-Outlining-2026-Strategic-Initiatives.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","INMB","BK4215","MAA","BK4588","BK4139"],"gpt_icon":0},{"id":"2592168197","title":"INmune Bio Inc: Files for Common Stock Offering of $65 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2592168197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592168197?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:03","pubTimestamp":1766178198,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2590315553","title":"INmune Bio Inc - Company Terminates Sales Agreement Effective December 19, 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590315553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590315553?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:21","pubTimestamp":1765401665,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG0VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2590365680","title":"INmune Bio Inc - on Dec 5,  Enters Amendment No. 5 to Rights Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590365680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590365680?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:02","pubTimestamp":1765227751,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE1GW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2589817780","title":"INmune Bio Reports Phase 2 Trial Data Showing XPro1595 Slows Neurodegeneration in Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2589817780","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589817780?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:01","pubTimestamp":1764968478,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. has announced new neuroimaging data from its Phase 2 MINDFuL trial evaluating XPro1595 in patients with early Alzheimer's disease and elevated neuroinflammation. The results, which will be presented at the 18th Clinical Trials on Alzheimer's Disease  conference held December 1-4, 2025, indicate that XPro1595 may slow disease progression, as evidenced by a trend toward reduced cortical disarray in dose-compliant participants. Additional MRI analyses from the trial are ongoing, with further data expected to be reported in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL3rksrv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2589659894","title":"INmune Bio Highlights CORDStrom Platform’s Promise in Stromal Cell Therapy Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2589659894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589659894?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:00","pubTimestamp":1764936015,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. has highlighted a recently published peer-reviewed article discussing the therapeutic potential of mesenchymal stromal cell  therapies, including its own CORDStrom platform. The overview, published in the journal Cytotherapy, was co-authored by Dr. Nikita M. Patel, INmune Bio's lead scientist for CORDStrom R&D. The article reviews current knowledge and critical gaps in MSC research, focusing on topics such as systemic and local delivery and in vivo persistence. While the results were published in the journal and not presented at a conference, INmune Bio noted that CORDStrom is initially being developed for Recessive Dystrophic Epidermolysis Bullosa , with regulatory filings expected in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL5cpHwq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4139","INMB","LU2210150020.SGD","BK4585","BK4588","LU2210149790.SGD","NDAQ","BK4112"],"gpt_icon":0},{"id":"2588872024","title":"INmune Bio Inc. Updates Executive Compensation Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2588872024","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588872024?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:16","pubTimestamp":1764796570,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. has amended the employment agreements of its President and Chief Executive, David J. Moss, and its Chief Financial Officer, Cory Ellspermann. David J. Moss's base salary has been restated to $454,000 per year, and his stock option grant has been updated to 750,000 shares under the company's stock incentive plan. Cory Ellspermann's base salary has been restated to $240,000 per year. These changes correct errors in their original agreements dated November 26, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLcbV63l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2588720308","title":"INmune Bio Reports Positive Phase 2 Imaging Data for XPro1595 in Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720308","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588720308?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:00","pubTimestamp":1764594038,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. has announced new neuroimaging data from its Phase 2 MINDFuL trial of XPro1595, a selective soluble TNF neutralizer, in patients with early Alzheimer's disease and elevated neuroinflammation. The results will be presented at the 18th Clinical Trials on Alzheimer's Disease  conference, taking place December 1-4, 2025, in San Diego, California. The study evaluated changes from baseline at 24 weeks using PerpPD+, a grey matter imaging analysis, in participants with early Alzheimer's disease and a high inflammatory burden. Secondary outcome measures included cortical disarray measurement , which showed a trend for reduced cortical disarray in dose-compliant participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDLWsCTN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","NDAQ","BK4112","BK4585","LU2210150020.SGD","INMB","LU0314104364.USD"],"gpt_icon":0},{"id":"2584359958","title":"INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584359958","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584359958?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:00","pubTimestamp":1763470800,"startTime":"0","endTime":"0","summary":"Boca Raton, FL, Nov.  18, 2025  (GLOBE NEWSWIRE) --  INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/18/3189923/0/en/INmune-Bio-Announces-Two-Presentations-at-the-Upcoming-18th-Annual-CTAD-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2579177460","title":"INmune Bio Q3 net loss narrows to $6.5 mln, names new CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2579177460","media":"Reuters","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579177460?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:30","pubTimestamp":1761856207,"startTime":"0","endTime":"0","summary":"INmune Bio Q3 net loss narrows to $6.5 mln, names new CEOOverviewINmune Bio Q3 net loss narrows to $6.5 mln from $12.1 mln year-over-yearOperating expenses for Q3 decreased to $7.4 mln from $12.3 mln ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nL1N3WB1MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2579740511","title":"INmune Bio Q3 Adj. EPS $(0.24) Beats $(0.33) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2579740511","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579740511?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:14","pubTimestamp":1761855246,"startTime":"0","endTime":"0","summary":"INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.33) by 26.15 percent. This is a 60 percent increase over losses of $(0.60) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48544031/inmune-bio-q3-adj-eps-0-24-beats-0-33-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","INMB","PSQ",".IXIC","SQQQ","USJW.SI","QID","TSYW.SI","NVIW.SI","USAW.SI","MNQmain","BK4139","QLD","NQmain"],"gpt_icon":0},{"id":"2579171019","title":"INmune Bio Q3 Basic EPS USD -0.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2579171019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579171019?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:05","pubTimestamp":1761854705,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nPLXF58A9F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2579117282","title":"INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2579117282","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579117282?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:05","pubTimestamp":1761854700,"startTime":"0","endTime":"0","summary":"Company to Host Conference Call Today, October 30, at 4:30pm ETBOCA RATON, Fla., Oct.  30, 2025  (GLOBE NEWSWIRE) -- INmune Bio Inc.(NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177900/0/en/INmune-Bio-Inc-Announces-Third-Quarter-2025-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB","ARIA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}